GG
CVS icon

Gofen & Glossberg’s CVS Health CVS Stock Holding History

Gofen & Glossberg’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.21M Buy
34,429
+3,172
+10% +$306K 0.08% 163
2022
Q3 		$2.98M Sell
31,257
-392
-1% -$38.8K 0.08% 165
2022
Q2 		$2.93M Buy
31,649
+267
+0.9% +$26.1K 0.08% 170
2022
Q1 		$3.18M Sell
31,382
-277
-0.9% -$29.1K 0.07% 168
2021
Q4 		$3.27M Buy
31,659
+228
+0.7% +$21.1K 0.07% 168
2021
Q3 		$2.67M Sell
31,431
-323
-1% -$27.1K 0.06% 179
2021
Q2 		$2.65M Buy
31,754
+1,813
+6% +$148K 0.06% 177
2021
Q1 		$2.25M Buy
29,941
+137
+0.5% +$9.98K 0.06% 178
2020
Q4 		$2.04M Sell
29,804
-2,216
-7% -$144K 0.06% 176
2020
Q3 		$1.87M Sell
32,020
-805
-2% -$50.1K 0.06% 170
2020
Q2 		$2.13M Sell
32,825
-2,301
-7% -$145K 0.07% 152
2020
Q1 		$2.08M Sell
35,126
-1,269
-3% -$84.7K 0.08% 147
2019
Q4 		$2.7M Sell
36,395
-1,343
-4% -$94.3K 0.09% 144
2019
Q3 		$2.38M Buy
37,738
+1,634
+5% +$96.8K 0.08% 150
2019
Q2 		$1.97M Sell
36,104
-13,836
-28% -$745K 0.07% 165
2019
Q1 		$2.69M Buy
49,940
+6,022
+14% +$372K 0.1% 139
2018
Q4 		$2.88M Buy
43,918
+17,309
+65% +$1.29M 0.11% 131
2018
Q3 		$2.1M Sell
26,609
-1,458
-5% -$104K 0.07% 166
2018
Q2 		$1.81M Sell
28,067
-6,308
-18% -$416K 0.07% 172
2018
Q1 		$2.14M Sell
34,375
-1,913
-5% -$137K 0.08% 160
2017
Q4 		$2.63M Sell
36,288
-13,000
-26% -$945K 0.09% 152
2017
Q3 		$4.01M Sell
49,288
-6,352
-11% -$502K 0.15% 119
2017
Q2 		$4.48M Buy
55,640
+965
+2% +$76.2K 0.17% 113
2017
Q1 		$4.29M Sell
54,675
-948
-2% -$75.7K 0.17% 113
2016
Q4 		$4.39M Sell
55,623
-4,117
-7% -$333K 0.18% 107
2016
Q3 		$5.32M Buy
59,740
+1,058
+2% +$99.9K 0.22% 97
2016
Q2 		$5.62M Buy
58,682
+3,533
+6% +$352K 0.24% 94
2016
Q1 		$5.72M Buy
55,149
+2,438
+5% +$237K 0.24% 94
2015
Q4 		$5.15M Buy
52,711
+11,621
+28% +$1.14M 0.22% 103
2015
Q3 		$3.96M Buy
41,090
+12,949
+46% +$1.36M 0.18% 112
2015
Q2 		$2.95M Buy
28,141
+7,052
+33% +$721K 0.12% 135
2015
Q1 		$2.18M Sell
21,089
-10
-0% -$1.01K 0.09% 157
2014
Q4 		$2.03M Buy
21,099
+11,077
+111% +$976K 0.09% 162
2014
Q3 		$798K Buy
10,022
+4,335
+76% +$342K 0.04% 226
2014
Q2 		$429K Buy
5,687
+242
+4% +$18.3K 0.02% 289
2014
Q1 		$398K Buy
5,445
+2,355
+76% +$166K 0.02% 296
2013
Q4 		$221K Hold
3,090
– – 0.01% 384
2013
Q3 		$175K Buy
3,090
+75
+2% +$4.47K 0.01% 405
2013
Q2 		$172K Buy
+3,015
New +$175K 0.01% 386

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gofen & Glossberg's CVS Position: Q4 2022 in Review

Gofen & Glossberg increased its CVS Health (CVS) stake by 10% in Q4 2022, buying an estimated $306K and bringing the position to 34,429 shares worth $3.21M. The position accounts for 0.08% of the portfolio, ranked #163.

Gofen & Glossberg first reported a position in CVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $5.72M in Q1 2016. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Gofen & Glossberg held 34,429 shares of CVS Health worth $3.21M as of Q4 2022.
  • Gofen & Glossberg bought 3,172 CVS Health shares in Q4 2022, an estimated $306K.
  • CVS Health made up 0.08% of Gofen & Glossberg's portfolio in Q4 2022, its #163 holding.
  • Gofen & Glossberg first reported a position in CVS Health in Q2 2013 and has held it in 39 quarters since.
  • Gofen & Glossberg's CVS Health position peaked at $5.72M in Q1 2016.
  • 2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.